Wenn derzeit an einem Impfstoff oder einem Medikament gegen das Corona-Virus geforscht wird, dann kommen in Laboren möglicherweise Produkte zum Einsatz, die aus Schweden stammen.
This announcement is not an offer, whether directly or indirectly, in Australia, Belarus, Canada, Hong Kong, Japan, New Zealand, Russia, Singapore, South Africa or in any...
Swedens Biotage said on Tuesday that KKR had made a cash offer for the Swedish biotechnology firm, valuing it at around 11.6 billion Swedish crowns ($1.22 billion).
KKR makes $1.2 billion offer for Sweden’s Biotage
Private equity firm KKR & Co. continued its spurt of acquisitions amid widespread market volatility by making a take-private offer for Swedish life sciences group Biotage...
